The Effect of Berberine on Lipid Profile, Liver Enzymes, and Fasting Blood Glucose in Patients with Non-alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial

Background: Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver disorders with a relatively high mortality rate. Berberine has recently been found to have some antidiabetic and antihyperlipidemic effects, although the evidence of its effectiveness in NAFLD is limited. To assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Nejati, Lida, Movahedi, Ariyo, Salari, Gholamreza, Moeineddin, Reza, Nejati, Parisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448505/
https://www.ncbi.nlm.nih.gov/pubmed/36128280
http://dx.doi.org/10.47176/mjiri.36.39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448505/
https://www.ncbi.nlm.nih.gov/pubmed/36128280
http://dx.doi.org/10.47176/mjiri.36.39

Ejemplares similares